Levin Capital Strategies’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Levin Capital Strategies’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-36,900	Closed	-$6.38M	–	441
2015 Q1	$6.38M	Buy	36,900 +23,946	+185%	+$3.52M	0.1%	118
2014 Q4	$1.49M	Sell	12,954 -9,376	-42%	-$1.14M	0.02%	183
2014 Q3	$3.49M	Buy	+22,330	New	+$3.24M	0.05%	142

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Levin Capital Strategies's SLXP Position: Q2 2015 in Review

Levin Capital Strategies sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 36,900 shares — an estimated $6.38M sold.

Levin Capital Strategies first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $6.38M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Levin Capital Strategies reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Levin Capital Strategies sold 36,900 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $6.38M.
Levin Capital Strategies first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
Levin Capital Strategies's SALIX PHARMACEUTICALS LTD DEL position peaked at $6.38M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Levin Capital Strategies's 13F filing for Q2 2015, filed 12 Aug 2015.